Alginate-based powder wound dressing

Assessment of safety of alginate-based powder wound dressing in treatment of burn wounds (Algipoon)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240617062158N1

Enrollment

Registered

2024-06-22

Start date

2024-07-19

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

2A degree burn wound. Burn of second degree of ankle and foot

Interventions

Intervention 1: Treated with a powder dressing containing alginate to the wound bed (0.1 gram per square centimeter) in grade 2A burn wounds that is bandaged every other day for up to 14 days. Interve

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Presence of 2A degree burns in the upper limbs such as both hands

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Wound size. Timepoint: At the beginning of the study and 7 and 14 days after the treatment. Method of measurement: Imaging and measuring the area of ??the remaining wound by the software.;Age. Timepoint: At the beginning of the study and 7 and 14 days after the treatment. Method of measurement: Questionnaire.;Gender. Timepoint: At the beginning of the study and 7 and 14 days after the treatment. Method of measurement: Questionnaire.;Percentage of healing in patients according to the type of treatment. Timepoint: At the beginning of the study and 7 and 14 days after the treatment. Method of measurement: Statistics calculations.	—

Measure

Time frame

Wound size. Timepoint: At the beginning of the study and 7 and 14 days after the treatment. Method of measurement: Imaging and measuring the area of ??the remaining wound by the software.;Age. Timepoint: At the beginning of the study and 7 and 14 days after the treatment. Method of measurement: Questionnaire.;Gender. Timepoint: At the beginning of the study and 7 and 14 days after the treatment. Method of measurement: Questionnaire.;Percentage of healing in patients according to the type of treatment. Timepoint: At the beginning of the study and 7 and 14 days after the treatment. Method of measurement: Statistics calculations.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Zare

Zharfandishan Fanavar Zistbaspar

zmary1392@gmail.com+98 21 2248 5514

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026